| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| cpi-1205 | enhancer of zeste homolog 2 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] B-Cell Lymphomas[MeSHID:D016393] Malignant neoplasm of prostate[MeSHID:D011471] |
23.87 | phase 1/2 | unknown |
| cpi-1205 | enhancer of zeste homolog 2 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] B-Cell Lymphomas[MeSHID:D016393] Malignant neoplasm of prostate[MeSHID:D011471] |
23.87 | phase 1/2 | inhibitor |
| cpi-1205 | histone-lysine n-methyltransferase ezh2 | small molecule | NA | drugbank , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] B-Cell Lymphomas[MeSHID:D016393] Malignant neoplasm of prostate[MeSHID:D011471] |
23.87 | investigational | inhibitor |
| click here to return to the previous page | ||||||||